181 related articles for article (PubMed ID: 15316565)
1. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
[TBL] [Abstract][Full Text] [Related]
3. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
4. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
[TBL] [Abstract][Full Text] [Related]
5. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
[TBL] [Abstract][Full Text] [Related]
6. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
[TBL] [Abstract][Full Text] [Related]
7. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
[TBL] [Abstract][Full Text] [Related]
8. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
[TBL] [Abstract][Full Text] [Related]
9. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Ashley SW; Whang EE
J Biol Chem; 2004 May; 279(22):23176-82. PubMed ID: 15047698
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6.
Han HS; Son SM; Yun J; Jo YN; Lee OJ
FEBS Lett; 2014 Oct; 588(20):3744-50. PubMed ID: 25171863
[TBL] [Abstract][Full Text] [Related]
13. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
Deng X; Liu P; Zhao Y; Wang Q
Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
[TBL] [Abstract][Full Text] [Related]
16. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
Cheng TM; Murad YM; Chang CC; Yang MC; Baral TN; Cowan A; Tseng SH; Wong A; Mackenzie R; Shieh DB; Zhang J
Eur J Cancer; 2014 Mar; 50(4):713-21. PubMed ID: 22918079
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
Liau SS; Jazag A; Whang EE
Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
[TBL] [Abstract][Full Text] [Related]
18. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
[TBL] [Abstract][Full Text] [Related]
19. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Feb; 23(7):1448-56. PubMed ID: 14973554
[TBL] [Abstract][Full Text] [Related]
20. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]